1. Pharmaceuticals Research and Manufacturers of America. New medicines in development for cancer. Washington, DC: PhRMA 2001, pp. 1–56.
2. American Cancer Society. Cancer Facts and Figures 2001. Atlanta, GA: American Cancer Society, 2001.
3. Parexel’ s Pharmaceutical R&D Statistical Sourcebook 2001. Boston, MA: Parexel International Corporation, 2002.
4. Lasagna L, Frei E III. The impact of regulations, tradition, and experimental design on clinical cancer trials: report and recommendations resulting from Washington Cancer Trials Conference. Am J Clin Oncol 1996; 19: 325–329.
5. DiMasi JA, Bryant NR, Lasagna L. New drug development in the United States from 1963 to 1990. Clin Pharmacol Ther 1991; 50: 471–486.